WHITEPAPER – Must-Use Strategies to Successfully Transfer & Scale Your Pharmaceutical Product


Pharmaceutical companies are turning more frequently to external manufacturing partners for their development and production needs. A cornerstone of modern drug development strategy, contract development and manufacturing organizations (CDMOs) now produce about 28% of the world’s prescription and non-prescription drugs.¹ Not surprisingly, contract pharma’s share is set to increase, as owner’s and sponsors turn to the operational excellence of CDMO partners to unleash the potential of their intellectual property (IP). Click here to download/view PDF of entire whitepaper.